Genetic and Biochemical Studies of KSHV LANA
KSHV LANA 的遗传和生化研究
基本信息
- 批准号:10599894
- 负责人:
- 金额:$ 65.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAfrica South of the SaharaAnimal ModelBindingBiochemicalBiologicalBiological AssayC-terminalCell NucleusCell ProliferationCell SurvivalCellsDNADNA Binding DomainDNA biosynthesisDaughterDevelopmentDiseaseElementsEpidemicEpisomeEtiologyGenesGeneticGenomeGlycogen Synthase Kinase 3Herpesviridae InfectionsHistone H2AHumanHuman Herpesvirus 8Immunocompromised HostInvestigationKaposi SarcomaLinkLysineMaintenanceMalignant NeoplasmsMediatingMitotic ChromosomeMolecularMulticentric Angiofollicular Lymphoid HyperplasiaMusN-terminalNucleosomesOncoproteinsOral cavityOrganPhosphorylation SitePlasmidsProliferatingProteinsReaderRepetitive SequenceRoleSequence DeletionSequence HomologsSpecificitySurfaceTP53 geneTerminal Repeat SequencesViralViral GenomeVirusVirus ReplicationVisceralWorkantigen bindingdaughter cellexperimental studygamma-2 herpesvirusgammaherpesvirusgenetic approachin vivoinsightinterestlatency-associated nuclear antigenneoplastic cellnovelnovel strategiespreventprimary effusion lymphomasegregationtumorubiquitin-protein ligaseviral DNA
项目摘要
Kaposi's sarcoma (KS)-associated herpesvirus (KSHV or HHV8) is the causative agent of KS, primary
effusion lymphoma (PEL) and multicentric Castleman's disease. These tumors occur in AIDS and other
immunocompromised states. There are no specific therapies for these diseases. KS is the leading AIDS
malignancy, and is epidemic in sub Saharan Africa. KS often involves the oral cavity and can disseminate to
visceral organs. KSHV latently infects tumor cells and viral genomes persist as circular, multiple copy,
extrachromosomal, episomes (plasmids). In order to persist in proliferating cells, episomes must first replicate
and then efficiently segregate to daughter nuclei. Tumor cell viability is dependent on latent KSHV infection.
The latency-associated nuclear antigen (LANA) mediates KSHV episome persistence and this function
is essential for virus survival. Therefore, LANA function is of fundamental importance. LANA represents the
Achilles heel of KSHV as its disruption is lethal to the virus. LANA is necessary and sufficient for KSHV
episome maintenance in the absence of other virus genes.
Episome persistence is comprised of two components: 1) replication of viral DNA and 2) segregation of
the replicated episomes to progeny cell nuclei. LANA mediates both these functions. C-terminal LANA binds
specific sequence in KSHV terminal repeat (TR) DNA to mediate DNA replication. LANA tethers TR DNA to
mitotic chromosomes to segregate genomes to daughter nuclei. To form a molecular tether, the C-LANA DNA
binding domain (DBD) binds TR DNA and N-LANA simultaneously binds histones H2A/H2B at the folded
portion of the nucleosome. In addition to N- and C-LANA, internal LANA sequence is also critical for episome
persistence.
We have discovered two distinct internal LANA regions, one comprised of unique sequence, and one
within repetitive sequence, that are critical for LANA mediated episome persistence. The unique sequence
contains three distinct functional motifs, whereas the repetitive region is homologous to a host cell “reader”
sequence. Both of these regions will be investigated in this work.
This work will use a detailed, in depth approach to investigate each of the recently identified LANA
functional sequences. Experiments will use a rigorously developed panel of assays to identify the functional
motif and determine the mechanism through which the unique sequence mediates episome persistence. The
repetitive LANA effector sequence homologous to host “reader” sequence will be investigated to determine the
mechanism through which it exerts its function. This work will provide important insight into LANA’s
fundamental function of episome maintenance, and may lead to novel strategies to prevent or treat KSHV
associated malignancies.
卡波西肉瘤 (KS) 相关疱疹病毒(KSHV 或 HHV8)是 KS 的病原体,原发性
渗出性淋巴瘤(PEL)和多中心卡斯尔曼病这些肿瘤发生在艾滋病和其他疾病中。
KS 是主要的艾滋病,目前尚无针对这些疾病的具体治疗方法。
KS 是一种恶性肿瘤,在撒哈拉以南非洲地区流行,通常累及口腔,并可传播到口腔。
KSHV 潜伏感染肿瘤细胞,病毒基因组以环状、多拷贝形式存在。
染色体外的附加体(质粒) 为了在增殖细胞中持续存在,附加体必须首先进行复制。
然后有效分离到子细胞核 肿瘤细胞的活力取决于潜伏的 KSHV 感染。
潜伏期相关核抗原 (LANA) 介导 KSHV 游离体持久性及其功能
因此,LANA功能对于病毒的生存至关重要。
KSHV 的致命弱点是 LANA 的破坏对于 KSHV 来说是必要且充分的。
在没有其他病毒基因的情况下维持附加体。
附加体持久性由两个部分组成:1) 病毒 DNA 的复制和 2) 病毒 DNA 的分离
复制到子代细胞核的附加体介导这两种功能。
KSHV 末端重复 (TR) DNA 中的特定序列介导 DNA 复制。
有丝分裂染色体将基因组分离到子核,形成分子系链 C-LANA DNA。
结合域 (DBD) 结合 TR DNA,N-LANA 在折叠处同时结合组蛋白 H2A/H2B
除了 N- 和 C-LANA 之外,内部 LANA 序列对于附加体也至关重要。
坚持。
我们发现了两个不同的内部 LANA 区域,一个由独特的序列组成,另一个由
在重复序列中,这对于 LANA 介导的附加体持久性至关重要。
包含三个不同的功能基序,而重复区域与宿主细胞“阅读器”同源
本工作将研究这两个区域。
这项工作将使用详细、深入的方法来调查最近识别的每个 LANA
实验将使用严格开发的检测组来鉴定功能序列。
基序并确定独特序列介导附加体持久性的机制。
将研究与宿主“阅读器”序列同源的重复 LANA 效应子序列,以确定
这项工作将为 LANA 提供重要的见解。
附加体维持的基本功能,并可能导致预防或治疗 KSHV 的新策略
相关恶性肿瘤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kenneth M Kaye其他文献
Kenneth M Kaye的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kenneth M Kaye', 18)}}的其他基金
Genetic and Biochemical Studies of KSHV LANA
KSHV LANA 的遗传和生化研究
- 批准号:
10376856 - 财政年份:2020
- 资助金额:
$ 65.55万 - 项目类别:
Genetic and Biochemical Studies of KSHV LANA
KSHV LANA 的遗传和生化研究
- 批准号:
10025546 - 财政年份:2020
- 资助金额:
$ 65.55万 - 项目类别:
相似国自然基金
撒哈拉以南非洲植物多样性的时空格局和保护
- 批准号:32370217
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Genetic and Biochemical Studies of KSHV LANA
KSHV LANA 的遗传和生化研究
- 批准号:
10376856 - 财政年份:2020
- 资助金额:
$ 65.55万 - 项目类别:
Genetic and Biochemical Studies of KSHV LANA
KSHV LANA 的遗传和生化研究
- 批准号:
10025546 - 财政年份:2020
- 资助金额:
$ 65.55万 - 项目类别:
A Neonatal Monkey Model of Tuberculosis Vaccination
新生猴结核病疫苗接种模型
- 批准号:
9901954 - 财政年份:2019
- 资助金额:
$ 65.55万 - 项目类别:
Defining the protective efficacy of antibodies against the EBV gH/gL glycoprotein complex
定义针对 EBV gH/gL 糖蛋白复合物的抗体的保护功效
- 批准号:
10199986 - 财政年份:2019
- 资助金额:
$ 65.55万 - 项目类别: